Skip to main content

Table 2 Univariate predictors of RED events (N= 23,127 patient days)

From: Predicting out of intensive care unit cardiopulmonary arrest or death using electronic medical record data

Variable

Derivation

Events # (%)

Odds Ratio (95% CI)

p

RED events a

298 (1.3)

   

age > 54

9,217 (39.9)

145 (1.6)

1.4 (1.14 - 1.81)

0.002

Vitals, N(%)

Temperature (°F)

≤99.5 (ref.)

20,157 (87.2)

229 (1.1)

--

--

>99.5

2,970 (12.8)

69 (2.3)

2.1 (1.58 - 2.72)

<0.001

Systolic Blood Pressure (mm Hg)

≤125 (ref.)

7,122 (30.8)

77 (1.1)

--

--

>125

16,005 (69.2)

221 (1.4)

1.3 (0.99 - 1.66)

0.063

Respirations per minute

≤24 (ref.)

21,713 (93.9)

192 (0.9)

--

--

>24

1,414 (6.1)

106 (7.5)

9.1 (7.12 - 11.59)

<0.001

Pulse per minute

≤134 (ref.)

22,464 (97.1)

240 (1.1)

--

--

>134

663 (2.9)

58 (8.8)

8.9 (6.59 - 11.96)

<0.001

Diastolic Blood Pressure (mm Hg)

≤120 (ref.)

22,507 (97.3)

265 (1.2)

--

--

>120

620 (2.7)

33 (5.3)

4.7 (3.26 - 6.84)

<0.001

spO2 (%)

≤86

319 (1.4)

25 (7.8)

7.0 (4.59 - 10.74)

<0.001

>86 (ref.)

22,808 (98.6)

273 (1.2)

--

--

Laboratory, N(%)

Platelets (103 cells/mm3)

<100

1959 (8.5)

32 (1.6)

1.3 (0.90 - 1.89)

0.158

≥100 (ref.)

21,168 (91.5)

266 (1.3)

--

--

Potassium (mEq/L)

≤2.9

155 (0.7)

9 (5.8)

5.4 (2.74 - 10.76)

<0.001

2.9 - 5.1 (ref.)

21,811 (94.3)

245 (1.1)

--

--

>5.1

1,161 (5.0)

44 (3.8)

3.5 (2.50 - 4.81)

<0.001

Glucose (mg/dL)

≤250 (ref.)

22,219 (96.0)

276 (1.2)

--

--

250 – 600

825 (3.6)

17 (2.1)

1.7 (1.02 - 2.74)

0.042

>600

83 (0.4)

5 (6.0)

5.1 (2.05 - 12.69)

<0.001

Hematocrit (g/dL)

≤48 (ref.)

22,925 (99.1)

288 (1.3)

--

--

> 48

202 (0.9)

10 (5.0)

4.1 (2.15 - 7.81)

<0.001

Creatinine

≤1.5 (ref.)

17,937 (77.6)

201 (1.1)

--

--

>1.5

5,190 (22.4)

97 (1.9)

1.7 (1.32 - 2.15)

<0.001

White Blood Cell Count (103 cells/mm3)

≤11 (ref.)

19,225 (83.1)

204 (1.1)

--

--

>11

3,902 (16.9)

94 (2.4)

2.3 (1.80 - 2.95)

<0.001

Total Bilirubin (mg/dL)

≤1.7 (ref.)

22,172 (95.9)

271 (1.2)

--

--

>1.7

955 (4.1)

27 (2.8)

2.4 (1.57 - 3.51)

<0.001

Sodium (mEq/L)

≤128

983 (4.2)

29 (3.0)

2.5 (1.69 - 3.69)

<0.001

128 - 143 (ref.)

21,808 (94.3)

262 (1.2)

--

--

>143

336 (1.5)

7 (2.1)

1.7 (0.82 - 3.74)

0.148

pH

≤7.22

53 (0.2)

11 (20.8)

20.8 (10.60 - 40.80)

<0.001

>7.22 (ref.)

23,074 (99.8)

287 (1.2)

--

--

pCO2 (mm Hg)

≤22

78 (0.3)

12 (15.4)

14.8 (7.89 - 27.62)

<0.001

22 - 70 (ref.)

23,020 (99.5)

280 (1.2)

--

--

>70

29 (0.2)

6 (20.7)

21.2 (8.56 - 52.43)

<0.001

AST (U/L)

≤250 (ref.)

22,826 (98.7)

279 (1.2)

--

--

>250

301 (1.3)

19 (6.3)

5.4 (3.37 - 8.79)

<0.001

Anion Gap

    

≤16 (ref.)

21,791 (94.2)

236 (1.1)

--

--

>16

1,336 (5.8)

62 (4.6)

4.4 (3.34 - 5.91)

<0.001

Albumin (g/dL)

< 3.5

2,779 (12.0)

54 (1.9)

1.6 (1.21 - 2.20)

0.001

≥3.5 (ref.)

20,348 (88.0)

244 (1.2)

--

--

B-type natriuretic peptide (pg/mL)

≤100 (ref.)

21,803 (94.3)

257 (1.2)

--

--

>100

1,324 (5.7)

41 (3.1)

2.7 (1.92 - 3.74)

<0.001

Thyroid Stimulating Hormone (μIU/mL)

≤0.4

60 (0.3)

3 (5.0)

4.1 (1.27 - 13.10)

0.018

0.4 - 5.4

610 (2.6)

7 (1.2)

0.9 (0.42 - 1.91)

0.784

>5.4

83 (0.4)

3 (3.6)

2.9 (0.91 - 9.26)

0.071

Not measured (ref.)

22,374 (96.7)

285 (1.3)

--

--

Estimated glomerular filtration rate (mL/min/1.73 m2)

≤30

3,009 (13.0)

57 (1.9)

1.6 (1.19 - 2.13)

0.002

>30 (ref.)

20,118 (87.0)

241 (1.2)

--

--

Physician Orders, N(%)

Bilevel positive airway pressure

122 (0.5)

11 (9.0)

7.8 (4.18 - 14.73)

<0.001

Arterial Blood Gas

1,436 (6.2)

104 (7.2)

8.7 (6.77 - 11.05)

<0.001

Troponin I

3,725 (16.1)

130 (3.5)

4.1 (3.28 - 5.22)

<0.001

Electrocardiogram

4,996 (21.6)

183 (3.7)

6.0 (4.71 - 7.54)

<0.001

Electroencephalogram

87 (0.4)

1 (1.2)

0.9 (0.12 - 6.41)

0.908

Telemetry

1,765 (7.6)

36 (2.0)

1.7 (1.18 - 2.38)

0.004

Stat order # 1 b

1,704 (7.4)

45 (2.6)

2.3 (1.65 - 3.13)

<0.001

Stat order # 2 c

2,476 (10.7)

70 (2.8)

2.6 (1.99 - 3.42)

<0.001

Administered Medications, N(%)

Institute of Safe Medication Practice High Alert Medication d

9,257 (40.0)

162 (1.8)

1.8 (1.43 - 2.26)

<0.001

Systemic Steroids e

758 (3.3)

13 (1.7)

1.4 (0.77 - 2.37)

0.292

Sodium Bicarbonate

423 (1.8)

16 (3.8)

3.1 (1.87 - 5.22)

<0.001

Lactulose or Rifaxamin

535 (2.3)

12 (2.2)

1.8 (1.00 - 3.21)

0.051

Antidote medication f

308 (1.3)

14 (4.6)

3.8 (2.18 - 6.54)

<0.001

More than one nephrotoxic agent taken concurrently g

3,580 (15.5)

60 (1.7)

1.4 (1.04 - 1.84)

0.026

More than one antibiotic agent taken concurrently h

2,549 (45.3)

46 (1.8)

1.5 (1.08 - 2.04)

0.015

Intravenous fluid bolus

1,270 (5.5)

55 (4.3)

4.0 (2.99 - 5.43)

<0.001

Stat acute coronary syndrome medications i

2,436 (10.5)

43 (1.8)

1.4 (1.04 - 1.99)

0.028

Stat seizure abatement medications j

1,069 (4.6)

31 (2.9)

2.4 (1.67 - 3.55)

<0.001

Summary Variables

MEWS, Mean (SD) k

2.28 (1.5)

 

1.6 (1.54 - 1.70)

<0.001

Level of Consciousness

    

0 – Alert

7,580 (32.8)

156 (2.1)

3.1 (2.41 - 4.00)

<0.001

1 – Responds to voice/new confusion/restlessness

543 (2.3)

23 (4.2)

6.5 (4.12 - 10.37)

<0.001

2 – Responds to pain

102 (0.4)

6 (5.9)

9.2 (3.95 - 21.55)

<0.001

3 – Unresponsive

32 (0.1)

13 (40.6)

101.1 (48.59 - 210.20)

<0.001

Not measured (ref.)

14,870 (64.3)

100 (0.7)

--

--

High Risk Floor Assignment, N(%) l

2,369 (10.2)

158 (6.7)

10.5 (8.35 - 13.27)

<0.001

  1. a Resuscitation events and death; b Stat orders for head magnetic resonance imaging or computed tomography scan, chest plain film x-rays or computed tomography scan, and abdominal ultrasonography; c Stat orders for complete blood count, bilevel positive airway pressure, arterial blood gas, troponin, electroencephalogram and electrocardiogram; d antithrombotic agents, chemotherapeutic agents, epidural or intrathecal route of administration, hypoglycemic, magnesium sulfate injection, hypertonic sodium chloride, colchicine injection, and methotrexate oral; e IV or oral prednisone, methylprednisolone, prednisolone, fludricortisone and hydrocortisone; f Protamine, naloxone, phytonadione, flumazenil; g Systemic amphotericin B (lipid and conventional), systemic aminoglycosides, scheduled daily non-steroidal anti-inflammatories, IV vancomycin, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, cyclosporine, tacrolimus, loop diuretics, penicillin antibiotics, acyclovir; h Any aminoglycoside, penicillin, cephalosporin, vancomycin, sulfa antibiotic, linezolid, doxycycline, tigecycline, fluoroquinolone, aztreonam, carbapenem, daptomycin, and nitrofurantoin; i IV metoprolol, sublingual or IV nitroglycerin and aspirin given concurrently; j intramuscular lorazepam or diazepam, phenobarbital, fosphenytoin, and phenytoin; k elements consists of systolic blood pressure, heart rate, respiratory rate, temperature, and level of consciousness; l includes floors that comprise the top 15% of events.